2013 – Timothy Henry, MD, FACC
Dr. Timothy Henry, director of research at the Minneapolis Heart Institute Foundation, is an interventional cardiologist at the Minneapolis Heart Institute/Abbott Northwestern Hospital and Professor of Medicine at University of Minnesota School of Medicine.
Dr. Henry graduated from medical school at University of California, San Francisco, in 1982 and was chief medicine resident from 1982–1986 at University of Colorado Health Sciences Center. He completed his training as a cardiology fellow, chief cardiology fellow, and interventional cardiology fellow at University of Minnesota in 1991. His research interests include interventional cardiology, acute myocardial infarction, and novel therapies, including stem cell and gene therapy, for patients who are not candidates for standard revascularization techniques.
Dr. Henry has published over 300 manuscripts, book chapters, and abstracts and has served on the Research Committee for the Minnesota Affiliate of the AHA and the Emergency Care Committee for the ACC; he currently serves on the Advisory Committee for the AHA Mission: Lifeline Model Evaluation Task Force, the AHA Acute Cardiac Care Committee of the Council on Clinical Cardiology and on the ACC Interventional Subcommittee. He has served on steering committees of large, multicenter trials in ACS and angiogenesis, including TIMI-9, IN-TIME, TACTICS, VIVA, AGENT III, and several ongoing myocardial and peripheral angiogenesis trials. He is also principal investigator for 1 of 5 NIH Clinical Cardiovascular Stem Cell Centers. He is a fellow at ACC and SCAI and a member of Alpha Omega Alpha and the AHA Council on Clinical Cardiology.
(source: http://www.mplsheart.org/leadership/timothy-henry-md-facc)
2012 – Yong Huo, MD, PhD
Yong Huo is the Professor of Cardiovascular Medicine and Head of the Department of Cardiology at Peking University First Hospital, Beijing, China. He is also the President Elect of China Society of Cardiology. Professor Huo completed his Master’s Degree in Medicine at Peking University. He was also a visiting scholar at Harvard Medical School, Boston, Massachusetts, USA, between 1993 and 1994.
A specialist in critical and complicated cardiovascular medicine, Prof Huo has particular clinical interests in Interventional Cardiology. For the past decade he has led research on percutaneous coronary angioplasty, coronary stenting and coronary rotablation. Currently, he is a heading a national STEMI study by the Chinese Ministry of Health.
(source: http://www.jgc301.com/ch/reader/view_editor.aspx?id=11061523344400150)
2011 – Alice Jacobs, MD
A professor of medicine and the Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Boston Medical Center, Dr. Alice Jacob has been very involved in the American Heart Association and the American College of Cardiology. Dr. Jacobs' major research activities are in the area of invasive cardiology and revascularization strategies. Currently she is the site principal investigator of several multi-center trials including the NHLBI funded BARI 2-D, SHOCK, and OAT trials and the NHLBI Dynamic Registry. She is also active in the area of heart disease in women and has evaluated the acute and long-term outcomes of percutaneous coronary intervention in women in comparison to men.
(source: http://www.bostoncardiovascular.org/handler.cfm?event=practice,template&cpid=50050)
2010 – William O’Neill, MD
A graduate of Wayne State University School of Medicine, Dr. O’Neill completed a cardiology fellowship at the University of Michigan Hospital. Dr. O’Neill served as the director of the Division of Cardiovascular Disease at William Beaumont Hospital. Prior to that he was director of the cardiac catheterization laboratory at the University of Michigan Hospital and an associate professor of medicine at the University of Michigan Hospital and Medical School. He was the executive dean for clinical affairs and the chief medical officer at University of Miami Miller School of Medicine. He has recently taken the role of medical director of the new Center for Structural Heart Disease at Henry Ford Hospital in Detroit.
An author of more than 300 articles and 400 abstracts published in medical literature, Dr. O’Neill is an international leader in the field of interventional cardiology and in the research of new techniques to diagnose and treat obstructed heart arteries. His pioneering work includes the mechanical rotary atherectomy technique, which uses a catheter with a rotating, diamond-tipped burr to carve away and disintegrate plaque that obstructs the arteries. In April 2008, Dr. O’Neill successfully performed two percutaneous valve replacements as part of a national clinical trial. The two patients were the first to undergo the procedure in Florida.
(source: http://uhealthsystem.com/doctors/profile/1642)
2009 – Samin Sharma, MD
Dr. Samin Sharma is the director of the cardiac catheterization laboratory at Mount Sinai hospital, director of clinical cardiology, and president of the Mount Sinai Heart Network. Dr. Samin K. Sharma performs over 1500 complex coronary interventions annually (the highest in the country) while achieving an extremely low complication rate. According to New York State Department of Health reports, he has the highest angioplasty success rate (lowest mortality less than 0.1 percent) for an interventional cardiologist in the state since 1994. Under Dr. Sharma's leadership, Mount Sinai Heart has become one of the best and busiest centers in New York, providing excellent care for all types of simple and complex high-risk heart patients. In addition to coronary interventions, Dr. Sharma specializes in the non-surgical treatment of mitral and aortic stenosis (balloon valvuloplasty).
Dr. Sharma is widely published on topics of rotational atherectomy, newer interventional devices and drug eluting stents, as well as how to reduce various complications of coronary intervention by the use of beta-blockers and GP IIb/IIIa inhibitors and appropriate techniques for the interventional devices. He is especially interested in discovering ways to treat and reduce in-stent restenosis. He heads CCC Live Cases, a monthly webcast of live demonstration of complex coronary cases.
(source: http://www.mountsinai.org/profiles/samin-k-sharma)
2008 – Martin Leon, MD
Dr. Martin Leon is Founder and Chairman Emeritus of the Cardiovascular Research Foundation and Professor of Medicine at Columbia University College of Physicians and Surgeons. Dr. Leon is also the Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center in New York City.
Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine. He has co-authored over 1,550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding subspecialty of interventional cardiovascular device and drug therapies.
(source: http://www.crf.org/aboutus/faculty-list.html)
